首页 › 湿疹 › 阿拉巴马州 › Birmingham
Birmingham AL 湿疹临床试验
7项针对 湿疹的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
招募中3 期
- Cahaba Dermatology & Skin Health Center, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
招募中1 期欢迎健康志愿者
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
招募中3 期
- Arcutis Site 324, Birmingham
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
招募中3 期
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology & Skin Health Center, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
招募中3 期
- Cahaba Dermatology & Skin Health Center, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
招募中2 期
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
招募中2 期
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
其他城市的 湿疹试验
- Los Angeles, CA6 项研究
- Miami, FL6 项研究
- New York City, NY5 项研究
- Little Rock, AR5 项研究
- San Antonio, TX5 项研究
- Huntington Beach, CA5 项研究
- Tampa, FL4 项研究
- Phoenix, AZ4 项研究
- San Diego, CA4 项研究
- Indianapolis, IN4 项研究
- Washington, DC4 项研究
- Santa Clarita, CA4 项研究
Birmingham的其他研究
- 癌症（所有类型）30 项研究
- 卵巢癌25 项研究
- 乳腺癌24 项研究
- 非小细胞肺癌23 项研究
- 肥胖症22 项研究
- 急性髓系白血病21 项研究
- 慢性阻塞性肺病17 项研究
- 多发性骨髓瘤17 项研究
- 心血管疾病16 项研究
- 子宫内膜癌16 项研究
- 超重16 项研究
- 2型糖尿病16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。